| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Applied Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 550,000 | $242,000 | $0.4400 | 24 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| APLT | Applied Therapeutics, Inc. | 24 Mar 2025 | 1 | $0 | 4 | Chief Commercial Officer | 26 Mar 2025, 20:25 |
| APLT | Applied Therapeutics, Inc. | 12 Apr 2024 | 1 | $0 | 4 | Chief Commercial Officer | 15 Apr 2024, 17:30 |
| APLT | Applied Therapeutics, Inc. | 12 Apr 2024 | 0 | $0 | 3 | Chief Commercial Officer | 15 Apr 2024, 17:27 |